|
|
|
|
|
Characters of Nutrition Status and Energy-delivery Patterns of the University-based Surgical Intensive Care Units in Thailand (Multi-center THAI-SICU Study) |
2561 |
# |
|
|
|
|
|
Characterizing the role of adaptor protein 1A in the basolateral targeting of kAE1 |
2554 |
# |
|
|
|
|
|
Characterizing the relationship between systemic inflammatory response syndrome and early cardiac dysfunction in traumatic brain injury |
2560 |
# |
|
|
|
|
|
Characterizing HIV manifestations and treatment outcomes of perinatally infected adolescents in Asia |
2560 |
# |
|
|
|
|
|
Characterizing HIV Manifestations and Treatment Outcomes of Perinatally Infected Adolescents in Asia |
2557 |
# |
|
|
|
|
|
Characterizations of urinary sediments precipitated after freezing and their effects on urinary protein and chemical analyses. |
2552 |
# |
|
|
|
|
|
Characterizations of PMCA2-interacting complex and its role as a calcium oxalate crystal-binding protein. |
2560 |
# |
|
|
|
|
|
Characterizations of HSP90-Interacting Complex in Renal Cells Using Tandem Affinity Purification and Its Potential Role in Kidney Stone Formation. |
2561 |
# |
|
|
|
|
|
Characterizations of heparin-binding proteins in human urine by affinity purification-mass spectrometry and defining "L-x(2,3)-A-x(0,1)-L" as a novel heparin-binding motif |
2559 |
# |
|
|
|
|
|
Characterizations and proteome analysis of platelet-free plasma-derived microparticles in beta-thalassemia/hemoglobin E patients |
2555 |
# |
|
|
|
|
|
Characterization of two distinct phospholipase C enzymes from Burkholderia pseudomallei. |
2550 |
# |
|
|
|
|
|
CHARACTERIZATION OF TREATMENT STRATEGIES FOR NEUROPATHIC PAIN: EVIDENCE FROM A PAIN SPECIALIST SETTING IN THAILAND |
2553 |
# |
|
|
|
|
|
Characterization of the novel spontaneously immortalized rat Muller cell line SIRMu-1 |
2562 |
# |
|
|
|
|
|
Characterization of the Chromosome 4 Genes That Affect Fluconazole-Induced Disomy Formation in Cryptococcus neoformans |
2555 |
# |
|
|
|
|
|
Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01 |
2564 |
# |
|
|
|
|
|
Characterization of seronegative neuromyelitis optica in 2016 |
2560 |
# |
|
|
|
|
|
Characterization of renal stone composition by using fast kilovoltage switching dual-energy computed tomography compared to laboratory stone analysis: a pilot study |
2561 |
# |
|
|
|
|
|
CHARACTERIZATION OF RECOMBINANT FLAGELLIN B PROTEIN FROM LEPTOSPIRA INTERROGANS |
2557 |
# |
|
|
|
|
|
Characterization of Low-Molecular Weight Proteins of Leptospirainterrogans serovar Autumnalis for Early Diagnosis of Leptospirosis |
2555 |
# |
|
|
|
|
|
Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma. |
2561 |
# |
|
|
|
|
|
Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma |
2560 |
# |
|
|
|
|
|
Characterization of limbal explant sites: Optimization of stem cell outgrowth in in vitro culture |
2563 |
# |
|
|
|
|
|
Characterization of ion channels in human coronary artery endothelial cells |
2558 |
# |
|
|
|
|
|
Characterization of IgE-binding proteins in the salivary glands of Simulium nigrogilvum (Diptera: Simuliidae). |
2562 |
# |
|
|
|
|
|
Characterization of human immunodeficiency virus type 1 CRF01_AE env genes derived from recently infected Thai individuals |
2557 |
# |
|
|
|
|
|
Characterization of human CD8 T cell responses in dengue virus infected patients from India. |
2559 |
# |
|
|
|
|
|
Characterization of Flagellotropic, Chi-Like Salmonella Phages Isolated from Thai Poultry Farms. |
2562 |
# |
|
|
|
|
|
Characterization of dengue virus NS1 stably expressed in 293T cell lines |
2550 |
# |
|
|
|
|
|
Characterization of conserved sequence elements in eukaryotic RNase P RNA reveals roles in holoenzyme assembly and tRNA processing |
2548 |
# |
|
|
|
|
|
Characterization of circulating monocytes expressing HLA-DR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury |
2548 |
# |